Journal rankings · indicator year 2013
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2013
Hematology journal rankings 2013
64 ranked journals · Subfield in Medicine
Hematology has 64 ranked journals in 2013. The median journal has an OJR of 0.71, below the world average of 1.00, up 0.01 on 2012; Q1 starts at OJR 1.13. The top three are Blood, Blood Reviews, and Leukemia.
Ranks and citation indicators: 2013. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2010–2012, the window the 2013 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery675
- Pulmonary and Respiratory Medicine266
- Public Health, Environmental and Occupational Health227
- Cardiology and Cardiovascular Medicine218
- Oncology170
- Infectious Diseases162
- Epidemiology157
- Endocrinology, Diabetes and Metabolism132
- Neurology132
- Radiology, Nuclear Medicine and Imaging129
- Physiology120
- Psychiatry and Mental health119
- Hematology64
Show all 42 subfields
- Orthopedics and Sports Medicine88
- Dermatology73
- Pediatrics, Perinatology and Child Health73
- Ophthalmology70
- Rheumatology56
- Obstetrics and Gynecology55
- Nephrology46
- Pharmacology40
- Reproductive Medicine40
- Complementary and alternative medicine39
- Geriatrics and Gerontology36
- Emergency Medicine34
- Otorhinolaryngology33
- Rehabilitation24
- Critical Care and Intensive Care Medicine22
- Pathology and Forensic Medicine22
- Hepatology18
- Genetics17
- Immunology and Allergy17
- Urology11
- Anesthesiology and Pain Medicine10
- Gastroenterology6
- Internal Medicine5
- Family Practice2
- Transplantation2
- Biochemistry1
- Health Informatics1
- Anatomy0
- Microbiology0
64 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2012. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2010–2012, the window the 2013 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2010–2012 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2004 to 2013. | Compare |
|---|---|---|---|---|---|---|---|
1BloodElsevier BV · United States | 3.01Q1 | 9.00 0.68 up from 2012 | 5,162 | 13% | $5,500 | ||
2Blood ReviewsElsevier BV · United Kingdom | 2.87Q1 | 7.00 1.09 down from 2012 | 101 | 28% | $5,220 | ||
3LeukemiaSpringer Nature · United Kingdom | 2.30Q1 | 6.92 0.14 up from 2012 | 1,079 | 46% | $5,190 | ||
4HematologyAmerican Society of Hematology · United States | 2.06Q1 | 5.95 0.52 up from 2012 | 267 | 26% | — | ||
5Transfusion Medicine ReviewsElsevier BV · United States | 1.92Q1 | 5.04 1.34 up from 2012 | 93 | 14% | $3,970 | ||
6Current Opinion in HematologyLippincott Williams & Wilkins · United States | 1.87Q1 | 5.36 0.31 up from 2012 | 203 | 27% | — | ||
7HaematologicaOAFerrata Storti Foundation · Italy | 1.79Q1 | 4.87 0.07 up from 2012 | 1,056 | 100% | $2,157 | ||
8Seminars in HematologyElsevier BV · United States | 1.79Q1 | 3.90 0.83 down from 2012 | 117 | 42% | $4,070 | ||
9Journal of Thrombosis and HaemostasisElsevier BV · United Kingdom | 1.71Q1 | 4.38 0.27 down from 2012 | 1,241 | 84% | $3,750 | ||
10British Journal of HaematologyWiley · United Kingdom | 1.65Q1 | 4.37 0.01 up from 2012 | 1,192 | 56% | $5,190 | ||
11Seminars in Thrombosis and HemostasisThieme Medical Publishers (Germany) · United States | 1.41Q1 | 3.56 0.73 down from 2012 | 369 | 32% | — | ||
12Transplantation and Cellular TherapyElsevier BV · Netherlands | 1.37Q1 | 3.67 0.03 up from 2012 | 763 | 100% | $3,650 | ||
13Best Practice & Research Clinical HaematologyElsevier BV · United Kingdom | 1.36Q1 | 3.79 0.62 down from 2012 | 155 | 13% | $3,730 | ||
14American Journal of HematologyWiley · United States | 1.24Q1 | 3.79 1.02 up from 2012 | 848 | 61% | $5,450 | ||
15Blood Cancer JournalOASpringer Nature · United Kingdom | 1.19Q1 | 3.23 2.19 up from 2012 | 98 | 100% | $5,290 | ||
16TransfusionWiley · United States | 1.13Q1 | 3.15 0.12 up from 2012 | 1,229 | 21% | $4,100 | ||
17Experimental HematologyElsevier BV · United States | 1.12Q2 | 2.85 0.90 down from 2012 | 363 | 97% | $3,250 | ||
18Vox SanguinisWiley · United Kingdom | 1.11Q2 | 2.84 0.28 up from 2012 | 302 | 19% | $4,150 | ||
19Current Hematologic Malignancy ReportsSpringer Science+Business Media · United States | 1.10Q2 | 3.41 0.60 up from 2012 | 105 | 27% | $3,790 | ||
20Bone Marrow TransplantationSpringer Nature · United Kingdom | 1.03Q2 | 2.66 0.02 down from 2012 | 846 | 24% | $4,990 | ||
21Bone Marrow ResearchHindawi Publishing Corporation · United Kingdom | 1.03Q2 | 2.41 0.54 down from 2012 | 45 | 100% | — | ||
22European Journal Of HaematologyWiley · United Kingdom | 1.03Q2 | 2.61 0.01 up from 2012 | 442 | 13% | $4,650 | ||
23Expert Review of HematologyTaylor & Francis · United Kingdom | 0.92Q2 | 2.37 0.25 down from 2012 | 200 | 29% | — | ||
24Journal of Clinical ApheresisWiley · United States | 0.92Q2 | 2.47 0.09 up from 2012 | 143 | 6% | $3,920 | ||
25Transfusion Medicine and HemotherapyOAKarger Publishers · Switzerland | 0.89Q2 | 2.69 1.29 up from 2012 | 173 | 90% | $1,670 | ||
26Cytometry Part B Clinical CytometryWiley · United States | 0.82Q2 | 2.61 0.50 down from 2012 | 161 | 33% | $3,800 | ||
27Pediatric RheumatologyOABioMed Central · United Kingdom | 0.77Q2 | 1.72 0.32 up from 2012 | 131 | 100% | $3,090 | ||
28PlateletsOAInforma · United Kingdom | 0.77Q2 | 2.17 0.17 down from 2012 | 372 | 28% | $2,970 | ||
29International Journal of HematologySpringer Science+Business Media · Japan | 0.72Q2 | 2.22 0.12 up from 2012 | 732 | 23% | $4,390 | ||
30Leukemia & lymphoma/Leukemia and lymphomaTaylor & Francis · Switzerland | 0.72Q2 | 2.06 0.23 up from 2012 | 1,384 | 28% | — | ||
31Annals of HematologyOASpringer Science+Business Media · Germany | 0.72Q2 | 1.96 0.11 down from 2012 | 768 | 14% | $4,590 | ||
32Journal of Blood MedicineOADove Medical Press · New Zealand | 0.72Q2 | 2.03 0.91 up from 2012 | 59 | 100% | $2,320 | ||
33Leukemia ResearchElsevier BV · United Kingdom | 0.71Q3 | 2.04 0.19 up from 2012 | 1,055 | 11% | $3,910 | ||
34Clinical Lymphoma Myeloma & LeukemiaElsevier BV · United States | 0.68Q3 | 1.94 0.13 up from 2012 | 362 | 34% | $3,890 | ||
35AnemiaOAHindawi Publishing Corporation · United Kingdom | 0.67Q3 | 1.98 0.30 up from 2012 | 66 | 100% | $1,100 | ||
36Cancer Genetics and CytogeneticsElsevier BV · United States | 0.67Q3 | —no 2012 value | 211 | — | — | ||
37Transfusion MedicineWiley · United Kingdom | 0.63Q3 | 1.59 0.33 up from 2012 | 194 | 13% | $3,700 | ||
38Blood Coagulation & FibrinolysisLippincott Williams & Wilkins · United Kingdom | 0.62Q3 | 1.66 0.27 up from 2012 | 467 | 4% | — | ||
39HaemophiliaWiley · United Kingdom | 0.61Q3 | 2.22 0.21 down from 2012 | 786 | 17% | $4,760 | ||
40International Journal of Laboratory HematologyWiley · United Kingdom | 0.60Q3 | 1.72 0.01 down from 2012 | 279 | 19% | $3,880 | ||
41Mediterranean Journal of Hematology and Infectious DiseasesOAPAGEPress (Italy) · Italy | 0.58Q3 | 1.49 0.14 up from 2012 | 180 | 100% | $647 | ||
42Annals of Laboratory MedicineOASeoul National University · South Korea | 0.58Q3 | 1.83 0.74 up from 2012 | 267 | 100% | — | ||
43HematologyOAManey Publishing · United Kingdom | 0.56Q3 | 1.58 0.01 up from 2012 | 248 | 97% | $2,557 | ||
44Transfusion and Apheresis ScienceElsevier BV · United Kingdom | 0.55Q3 | 1.21 0.19 down from 2012 | 336 | 6% | $3,160 | ||
45Leukemia Research and TreatmentHindawi Publishing Corporation · Egypt | 0.54Q3 | 1.48 0.73 up from 2012 | 30 | 100% | — | ||
46Journal of Pediatric Hematology/OncologyLippincott Williams & Wilkins · United States | 0.53Q3 | 1.15 0.15 down from 2012 | 660 | 11% | — | ||
47Pediatric Hematology and OncologyTaylor & Francis · United Kingdom | 0.49Q3 | 1.26 0.20 up from 2012 | 293 | 3% | — | ||
48HämostaseologieThieme Medical Publishers (Germany) · Germany | 0.48Q3 | 1.54 0.38 up from 2012 | 209 | 2% | — | ||
49ImmunohematologyExeley Inc · United States | 0.48Q4 | 1.20 0.52 up from 2012 | 68 | 14% | — | ||
50Transfusion Clinique et BiologiqueElsevier BV · France | 0.46Q4 | 0.81 0.12 down from 2012 | 185 | 1% | $1,820 |
Subfields of Medicine, with Hematology highlighted.
- Surgery675
- Pulmonary and Respiratory Medicine266
- Public Health, Environmental and Occupational Health227
- Cardiology and Cardiovascular Medicine218
- Oncology170
- Infectious Diseases162
- Epidemiology157
- Endocrinology, Diabetes and Metabolism132
- Neurology132
- Radiology, Nuclear Medicine and Imaging129
- Physiology120
- Psychiatry and Mental health119
- Orthopedics and Sports Medicine88
- Dermatology73
- Pediatrics, Perinatology and Child Health73
- Ophthalmology70
- Hematology64
- Rheumatology56
- Obstetrics and Gynecology55
- Nephrology46
- Pharmacology40
- Reproductive Medicine40
- Complementary and alternative medicine39
- Geriatrics and Gerontology36
- Emergency Medicine34
- Otorhinolaryngology33
- Rehabilitation24
- Critical Care and Intensive Care Medicine22
- Pathology and Forensic Medicine22
- Hepatology18
- Genetics17
- Immunology and Allergy17
- Urology11
- Anesthesiology and Pain Medicine10
- Gastroenterology6
- Internal Medicine5
- Family Practice2
- Transplantation2
- Biochemistry1
- Health Informatics1
- Anatomy0
- Microbiology0
Journals
Citations made in 2013. Corpus-wide, 76.9% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
24 additional Hematology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2010–2012, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2013. Publication window: 2010–2012. How these summaries are calculated
- Ranked journals
- 64
- Window papers (baseline)
- 32,125 +2.4% from indicator year 2010
- Median OJR
- 0.713 +15.7% from indicator year 2010
- Rising journals (2025)
- 5
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2010–2012 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 37 | 43 | 47 | 48 | 49 | 48 | 48 | 51 | 52 | 55 | 57 | 59 | 60 | 64 | 69 | 71 | 70 | 74 | 78 | 80 | 79 | 83 | 83 | 84 | 83 | 78 | |
| Window papers (baseline) | 15,676 | 17,554 | 18,321 | 19,931 | 20,773 | 22,160 | 23,086 | 23,968 | 25,638 | 27,756 | 31,370 | 32,535 | 33,270 | 32,125 | 33,484 | 34,476 | 35,772 | 36,578 | 37,717 | 39,004 | 40,629 | 43,037 | 45,948 | 47,337 | 47,502 | 47,302 | |
| Median OJR | 0.53 | 0.57 | 0.589 | 0.593 | 0.641 | 0.646 | 0.677 | 0.650 | 0.640 | 0.663 | 0.62 | 0.73 | 0.707 | 0.713 | 0.7205 | 0.716 | 0.7196 | 0.75 | 0.74 | 0.68294 | 0.711 | 0.682 | 0.68287 | 0.63 | 0.587 | 0.658 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.